Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dexatrim Natural

This article was originally published in The Tan Sheet

Executive Summary

Ephedrine-free formulation in 30-count blister packs, 90-count "value size" bottles began shipping Jan. 1, Chattem says. The firm also introduces 90-count bottles of Dexatrim Natural with ephedrine, previously available only in 30- and 60-count blister packs. First-ever bottle containers for Dexatrim line were instituted to compete with Metabolife's eponymous weight-loss supplement and Rexall's Metab-O-Lite. Ephedrine-free formula contains chromium, bitter orange, Siberian ginseng, green tea and vanadium, with 80 mg caffeine per serving, labeling states. Users are directed to take one caplet one to three times daily. Dedicated TV, radio ads slated to break this spring

You may also be interested in...



Schiff Green Tea Supplement Weighs Into Diet Market

Weider Nutrition is expanding its Schiff brand with the introduction of Green Tea Diet Tablets, expected to reach multi-channel nationwide distribution in May.

Schiff Green Tea Supplement Weighs Into Diet Market

Weider Nutrition is expanding its Schiff brand with the introduction of Green Tea Diet Tablets, expected to reach multi-channel nationwide distribution in May.

Schiff Green Tea Supplement Weighs Into Diet Market

Weider Nutrition is expanding its Schiff brand with the introduction of Green Tea Diet Tablets, expected to reach multi-channel nationwide distribution in May.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel